基于深度AI算法和单细胞测序分析,探索胃癌患者的免疫逃生机制
Wenli Chen1, Xiaohui Liu2, Houhong Wang1
1Department of General Surgery, The Affiliated Bozhou Hospital of Anhui Medical University, Bozhou, Anhui, China.
Journal of cellular and molecular medicine
|May 16, 2024
概括
这项研究开发了胃癌的预后模型,确定AIDPS是生存和免疫反应的关键因素. 向GHRL显示出个性化胃癌治疗的希望.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 胃癌是一个重大的全球健康挑战,患者对免疫治疗的反应有所变化.
- 了解免疫逃生机制对于提高治疗疗效至关重要.
研究的目的:
- 使用机器学习开发胃癌预后的预测模型.
- 调查AIDPS在免疫逃逸和免疫治疗反应中的作用.
- 为了确定胃癌的潜在治疗点.
主要方法:
- 对公共胃癌数据库的分析.
- 使用101个机器学习算法构建一个预测模型.
- 胃腺癌细胞系的单细胞测序分析.
- 研究基因表达,包括GHRL及其功能影响.
主要成果:
- 高AIDPS表达群体的生存率较低,基因组变异增加,免疫细胞透发生变化,与免疫疗法耐药性相关.
- 确定了三种潜在的药物,用于针对高AIDPS组.
- 在胃腺癌细胞中抑制GHRL表达减少了癌症活性,M2巨分化和侵入性.
结论:
- AIDPS是胃癌预后的关键因素,影响基因组不稳定性,免疫透和对免疫治疗的反应.
- 向GHRL是个性化胃癌治疗的有希望的策略.
- 这些发现为改善胃癌的临床管理提供了洞察力.
更多相关视频
09:24Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells
Published on: May 9, 2020
4.4K
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.2K
相关概念视频
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K